Mykare Health is a technology company.
Mykare Health has raised $2.0M across 1 funding round.
Mykare Health has raised $2.0M in total across 1 funding round.
Mykare Health has raised $2.0M in total across 1 funding round.
Mykare Health's investors include Malpani Ventures, V3 Ventures.
Mykare Health is a healthtech startup founded in 2021 (with operations scaling from 2022) that builds a full-stack platform for affordable elective and cosmetic surgeries, targeting India's underserved middle class of 400 million self-employed individuals.[1][2][3] It serves patients seeking minimally invasive procedures like orthopaedics, urology, laparoscopy, ophthalmology, and cosmetic surgeries, while partnering with small-to-medium hospitals and 1,000+ providers to solve issues of price opacity, poor patient experience, and underutilized infrastructure.[1][2][3] The platform manages the entire journey—from consultation and zero-cost EMI financing to postoperative home care—delivering 30-40% cost savings through upfront negotiated pricing and an asset-light, revenue-sharing model.[1][3] With operations in 12 South Indian cities (e.g., Kochi, Bengaluru, Chennai), it has facilitated 3.1K+ surgeries, 3.5K+ check-ups, and served 85K+ users, backed by a 75-person team and <$5M in funding.[1][4]
Mykare Health was co-founded in Kochi, India, by Sam (likely Samuel, focused on patient experience), Rahmathulla T.M., and Joash Philipose, blending domain expertise with tech to address fragmented elective surgery care.[1][2] The idea emerged from recognizing the "unorganised and broken" journey of preoperative consultations, pricing, and postoperative support, particularly for locals in Tier 1-2 cities.[1] Sam, driven by personal or professional insights into accessibility gaps, aimed to uplift patient outcomes and empower smaller hospitals via hyperlocal networks (99% patients within 10km).[1][3] Early traction was rapid: within a year, it built a 100+ hospital network with 4.5K beds; by recent milestones, it achieved profitability in three years through efficient ops and in-house AI tools.[1][3]
Mykare Health rides India's digital health aggregation wave, bridging affordability gaps in a $372B market shifting from brick-and-mortar to patient-centric models amid rising demand for elective care.[2][3] Timing aligns with post-pandemic trends like remote management, eICU, and care coordination, as BCG notes healthtech platforms like Mykare enable partnerships for underserved Tier 2+ cities.[2] Market forces—underutilized infra in small hospitals, 400M middle-class needs, and aggregator scalability—favor its growth, influencing the ecosystem by boosting hospital footfall, standardizing quality, and pioneering "fin-health" for self-employed segments.[1][3] It exemplifies how asset-light players democratize access, potentially evolving into a trusted "hospital chain" without physical assets.[2]
Mykare Health is poised to expand nationally beyond South India, leveraging profitability and its 1,000+ network to penetrate underserved markets with radiology, preventive care, and full-spectrum aggregation.[3] Trends like personalized digital care, AI ops, and fin-health integration will propel it, potentially scaling user base exponentially while maintaining trust-driven volume.[3] Its influence may grow as a pivotal aggregator in India's healthcare transformation, redefining accessibility for the masses and setting benchmarks for cost-effective, tech-enabled chains—echoing its mission to make quality surgery hassle-free from day one.[1][2]
Mykare Health has raised $2.0M across 1 funding round. Most recently, it raised $2.0M Seed in June 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jun 1, 2023 | $2.0M Seed | Malpani Ventures, V3 Ventures |